Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by TRUE Private Wealth Advisors

TRUE Private Wealth Advisors reduced its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 33.0% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 742 shares of the medical equipment provider’s stock after selling 365 shares during the quarter. TRUE Private Wealth Advisors’ holdings in Intuitive Surgical were worth $365,000 as of its most recent filing with the SEC.

A number of other large investors also recently bought and sold shares of the company. Ridgewood Investments LLC purchased a new stake in Intuitive Surgical in the 2nd quarter valued at approximately $26,000. Godsey & Gibb Inc. boosted its stake in shares of Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 35 shares in the last quarter. LRI Investments LLC acquired a new position in Intuitive Surgical during the first quarter worth $30,000. LGT Financial Advisors LLC raised its position in Intuitive Surgical by 415.4% in the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 54 shares in the last quarter. Finally, MidAtlantic Capital Management Inc. acquired a new stake in Intuitive Surgical in the third quarter valued at $33,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on the stock. Raymond James upped their price target on shares of Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research note on Monday, October 14th. BTIG Research increased their target price on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. Mizuho lifted their price target on shares of Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Leerink Partners upped their price target on Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. Finally, Robert W. Baird lifted their price objective on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a report on Thursday, October 17th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $526.06.

Insider Buying and Selling

In related news, CFO Jamie Samath sold 108 shares of the company’s stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the completion of the transaction, the chief financial officer now owns 8,757 shares of the company’s stock, valued at approximately $4,746,819.42. This represents a 1.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the completion of the transaction, the chief executive officer now owns 24,219 shares in the company, valued at approximately $12,391,166.97. This trade represents a 42.84 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 50,459 shares of company stock worth $26,080,251. 0.90% of the stock is owned by company insiders.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $542.00 on Friday. The firm has a market cap of $193.05 billion, a PE ratio of 87.14, a P/E/G ratio of 5.33 and a beta of 1.39. The firm has a 50 day simple moving average of $510.03 and a 200-day simple moving average of $469.00. Intuitive Surgical, Inc. has a 1-year low of $304.50 and a 1-year high of $552.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The company had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.